podophyllotoxin has been researched along with ldn 193189 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ | 1 |
| Chalasani, A; Kraniak, JM; Mattingly, RR; Wallace, MR | 1 |
2 other study(ies) available for podophyllotoxin and ldn 193189
| Article | Year |
|---|---|
Identification of potent Yes1 kinase inhibitors using a library screening approach.
Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship | 2013 |
Development of 3D culture models of plexiform neurofibroma and initial application for phenotypic characterization and drug screening.
Topics: Antineoplastic Agents; Benzimidazoles; Bone Morphogenetic Protein 2; Cell Culture Techniques; Cells, Cultured; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Genes, Neurofibromatosis 1; Genes, Reporter; Humans; Luminescent Proteins; MAP Kinase Kinase 1; Molecular Targeted Therapy; Neurofibroma, Plexiform; Neurofibromatosis 1; Phenotype; Podophyllotoxin; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; Receptor, IGF Type 1; Red Fluorescent Protein; Schwann Cells; Transduction, Genetic; Tumor Cells, Cultured | 2018 |